Merck bows outs of the COVID-19 vaccine program following unfavorable data

Merck & Co stock up 0.21% at closing despite company announcement regarding the COVID-19 vaccine


Merck & Co is bowing out of the COVID-19 vaccine program after unfavorable data showed that 2 experimental vaccines did not generate immune responses as anticipated.

The U.S. pharmaceutical giant was banking on its decision to go another direction than other vaccine manufacturers but failed to hit the mark during testing.
Governor Tom Wolf/Flickr

Merck’s (MRX) stock fell 1.1% on Monday. However, the stock was up 0.21% at closing, defying logic.

Screenshot via Google Finance

Please comment below. Share this post on Facebook, Twitter, Gab, and Telegram.

What's coming? Californians told to stay within 120 miles of their residence
The Shepard Ambellas Show is an all original fast-paced comedy, variety, news show where nearly everything goes. Shepard Ambellas is the founder and editor-in-chief of the popular independent news website (news and politics). Bethany Adoni sits shotgun. The Shepard Ambellas Show airs LIVE weekdays (Mon-Fri) on the Shepard Ambellas YouTube channel from 5-7 pm Eastern/4C/2P. (CLICK HERE TO SUBSCRIBE) Turn notifications on immediately. The show is nationally syndicated on iHeart Radio. An archived version of the show is also available on Apple Podcasts, Spotify, Google Podcasts, Castbox, Deezer, Podcast Addict, Podchaser, JioSaavn, and Spreaker for you listening pleasure.